AlmaM. A.van der MeiS. F.Melis-DankersB. J. M.van TilburgT. G.GroothoffJ. W., & SuurmeijerT. P. B. M. (2011). Participation of the elderly after vision loss. Disability and Rehabilitation, 33, 63–72.
BlackwellD. L.LucasJ. W., & ClarkeT. C. (2012). Summary health statistics for U.S. adults: National Health Interview Survey. Vital Health Statistics, 10, 260.
4.
CacciatoreF.AbeteP.MaggiS.LuchettiG.CalabreseC.ViatiL., … RengoF. (2004). Disability and 6-year mortality in elderly population: Role of visual impairment. Aging Clinical and Experimental Research, 16, 382–388.
5.
ChristS. L.LeeD. J.LamB. L.ZhengD. D., & ArheartK. L. (2008). Assessment of the effect of visual impairment on mortality through multiple health pathways: Structural equation modeling. Investigative Ophthalmology & Visual Science, 49, 3318–3323.
6.
CrewsJ. E., & CampbellV. A. (2004). Vision impairment and hearing loss among community-dwelling older Americans: Implications for health and functioning. American Journal of Public Health, 94, 823–829.
7.
CrewsJ. E.ChouC. F.ZhangX.ZackM. M., & SaaddineJ. B. (2014). Health-related quality of life among people aged ≥65 years with self-reported visual impairment: Findings from the 2006–2010 behavioral risk factor surveillance system. Ophthalmic Epidemiology, 21, 287–296.
8.
CrewsJ. E.JonesG. C., & KimJ. H. (2006). Double jeopardy: The effects of comorbid conditions among older people with vision loss. Journal of Visual Impairment & Blindness, 100, 824–848
EvansJ. R.SmeethL., & FletcherA. E. (2008). Hospital admissions in older people with visual impairment in Britain. BMC Ophthalmology, 8(16), doi:10.1186/1471-2415-8-16
11.
GelladW. F.GrenardJ. L., & MarcumZ. A. (2011). A Systematic review of barriers to medication adherence in the elderly: Looking beyond cost and regimen complexity. American Journal Geriatric Pharmacotherapy, 9, 11–23.
12.
GrunwaldJ. E.AlexanderJ.YingG. S.MaguireM.DanielE.Whittock-MartinR., … JaarB. G. (2012). Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. Archives of Ophthalmology, 130, 1136–1144.
13.
HughesC. M. (2004). Medication non-adherence in the elderly: How big is the problem?Drugs & Aging, 21, 793–811.
14.
JacobsJ. M.Hammerman-RozenbergR.MaaraviY.CohenA., & StessmanJ. (2005). The impact of visual impairment on health, function and mortality. Aging Clinical and Experimental Research, 17, 281–286.
15.
KempenG. I. J. M.BallemansJ.RanchorA. V.van RensG. H. M. B., & ZijlstraG. A. R. (2012). The impact of low vision on activities of daily living, symptoms of depression, feelings of anxiety and social support in community-living older adults seeking vision rehabilitation services. Quality of Life Research, 21, 1405–1411.
16.
KnudtsonM. D.KleinB. E.KleinR.CruickshanksK. J., & LeeK. E. (2005). Age-related eye disease, quality of life, and functional activity. Archives of Ophthalmology.123, 807–814.
17.
McCannR. M.JacksonA. J.StevensonM.DempsterM.McElnayJ. C., & CupplesM. E. (2012). Help needed in medication self-management for people with visual impairment: Case-control study. British Journal of General Practice, 62, e530–e537.
18.
McCartyC. A.NanjanM. B., & TaylorH. R. (2001). Vision impairment predicts 5 year mortality. British Journal of Ophthalmology, 85, 322–326.
19.
MurrayM. D.DarnellJ.WeinbergerM., & MartzB. L. (1986). Factors contributing to medication noncompliance in elderly public housing tenants. Drug Intelligence & Clinical Pharmacy, 20, 146–152.
20.
RovnerB. W.ZisselmanP. M., & Shmuely-DulitzkiY. (1996). Depression and disability in older people with impaired vision: A follow-up study. Journal of the American Geriatrics Society, 44, 181–184.
